Malaria Therapeutics Market To Be Dominated Artemisinin - Based Combination Therapy (ACT) - Based Drug Type Segment Through 2028
Increasing government initiatives and investment
on Malaria research and development is expected to drive the Global Malaria Therapeutics
Market in the forecast period 2024-2028.
According to the TechSci
Research report, “Malaria Therapeutics - Global
Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, Global Malaria therapeutics market is anticipated to upsurge at an
impressive rate in the forecast period of 2028. Favorable government
policies have a significant impact on the growth of the global Malaria therapeutics
market. Governments plays a critical role in providing funding for research and
development of new malaria therapeutics, as well as
in ensuring the availability and affordability of these treatments. For example,
if a government invests in research and development of new malaria therapeutics,
it can lead to the discovery of more effective and efficient drugs.
Additionally, if governments provide funding for the distribution of malaria therapeutics,
it can improve access to these drugs for people living in malaria-endemic
regions. Moreover, governments can also provide incentives to pharmaceutical
companies to invest in the development of new malaria therapeutics. For
instance, tax credits or subsidies can encourage companies to invest in
research and development of new drugs. As governments continue to prioritize
innovation and sustainability, it can be
expected to see further growth and development in the global malaria therapeutics
in the coming years.
However, some of the key
challenges facing the global malaria therapeutics market include the emergence
of drug-resistant strains of the malaria parasite, limited access to effective
treatments in low-income countries, and the high cost of some of the newer
drugs. However, ongoing research and development efforts hold promise for the development
of new and more effective treatments for malaria.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on the "Global Malaria Therapeutics Market"
Global Malaria Therapeutics
Market is segmented based on drug type, drug formulation, distribution channel and
region. Based on drug type, the global malaria therapeutics market is segmented
into Artemisinin-based combination therapy (ACT), Quinine, Chloroquine, and Others. Artemisinin-based combination
therapy (ACT) is currently the dominant drug type for treating malaria,
particularly for uncomplicated malaria caused by Plasmodium falciparum, which
is the most deadly type of malaria parasite. This is due to the high efficacy
of artemisinin and its derivatives in rapidly reducing the parasite load in the
bloodstream, combined with the slower-acting partner drugs that are included in
ACT regimens to prevent the development of resistance.Quinine and Chloroquine
were previously widely used to treat malaria but their use has been limited due
to the emergence of drug-resistant strains of the malaria parasite
Based on Drug Formulation, the global malaria therapeutics market
is fragmented into Tablets, Capsules, Injectables, and others. Tablets
are the dominant drug formulation for many types of medications, including
those used to treat malaria. This is because tablets are easy to manufacture,
transport, and store, and they are also convenient for patients to take, as
they can be swallowed with water and do not require any special equipment or
administration.
Major
companies operating in the global malaria therapeutics market are:
- Novartis AG
- Sanofi S.A
- Pfizer Inc
- GlaxoSmithKline
Plc
- Merck & Co Inc
- F. Hoffmann-La
Roche AG
- Medicines for
Malaria Venture
- 60°
Pharmaceuticals, Inc
- Cipla Limited
- Ajanta Pharma
Limited
Download Free Sample Report
Customers
can also request for 10% free customization on this report.
“Global
malaria therapeutics market is expected to grow significantly in the coming
years, driven by the increasing prevalence of malaria and the development of
new drugs and therapies. The market is highly competitive, with major players
investing in research and development to improve their product offerings. The
global effort to eradicate malaria is also expected to drive the growth of the
market, as governments and international organizations fund initiatives to
combat the disease. Despite the progress made in recent years, there is still a
need for more effective and affordable treatments, especially in low-income
countries where malaria is most prevalent. Overall, the malaria therapeutics
market is poised for growth and innovation as efforts to eliminate this deadly
disease continue. The growing awareness of malaria as a major public health
issue, combined with the above factors, is driving the growth of the malaria therapeutics
market during the forecast period,” said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based global management consulting firm.
“Malaria Therapeutics Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028, Segmented By Drug Type (Artemisinin-based
combination therapy (ACT), Quinine, Chloroquine, Others), By Drug Formulation
(Tablets, Capsules, Injectables, Others), By End User (Adults, Children,
Pregnant Women, Others), By Distribution Channel (Retail pharmacies, Hospitals,
Online pharmacies) By Region, and Competition,
has evaluated the future growth potential of global malaria therapeutics market
and provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in the global malaria therapeutics market.”
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com